ThriveAI | $1,200,000 | (May 14, 2025)
Optimal Dynamics | $40,000,000 | (May 14, 2025)
Remedy Plan Therapeutics | $18,000,000 | (May 14, 2025)
Somite AI
United States
- Boston, Massachusetts
- 14/05/2025
- Series A
- Undisclosed Amount
Somite.ai is developing AI foundation models for human stem cells to drive novel cell therapies at scale. We take a full-stack approach—generating data at 1,000x lower cost, training large-scale models with unmatched predictive power, and using these models to discover, refine, and optimize high-impact applications in cell therapy.
Our founding team includes repeat AI entrepreneur Dr. Micha Breakstone (Chorus.ai, acquired for $575M), the Head of the Fundamental AI Group at MIT (pioneered the foundational research on scaling laws), and four Harvard Medical School professors and National Academy of Sciences/Medicine members, including the Chair of the Genetics Department at HMS. Based in Boston and launching operations in January 2024, Somite has raised over $11M in pre-seed funding
- Industry Biotechnology Research
- Website https://www.somite.ai/
- LinkedIn https://www.linkedin.com/company/somite-therapeutics/
Related People
Micha Y. Breakstone 🇮🇱🎗️Co Founder
United States -
Austin, Texas
I’m a repeat entrepreneur who’s founded a few great businesses (e.g. chorus.ai), and am on a journey to make the world a slightly better place, one company at a time.
Complement 1 | $16,000,000 | (May 14, 2025)
ClearVector | $13,000,000 | (May 14, 2025)
Pluto Bio | $3,600,000 | (May 14, 2025)
Stackpack | $6,300,000 | (May 14, 2025)
veritree | $6,500,000 | (May 14, 2025)
Adopt AI | $6,000,000 | (May 14, 2025)
theom | $20,000,000 | (May 13, 2025)
InBrain Pharma | $2,000,943 | (May 13, 2025)